Hepatitis A Virus Antibodies (Total)
Also known as: HAVAB
Use
The Hepatitis A Virus Antibodies (Total) test is primarily used to assess immunity to Hepatitis A virus (HAV). It detects both IgG and IgM antibodies but does not differentiate between them. This test is not generally recommended for diagnosing acute HAV infection but can be helpful in evaluating immunization status and determining past exposure to the virus.
Special Instructions
This test is New York state approved. Serum should be separated from cells as soon as possible or within 2 hours of collection. Use ARUP standard transport tube for serum transfer.
Limitations
The assay does not differentiate between IgG and IgM antibodies. Specimens collected in citrate-based anticoagulants, those containing particulate material, or those that are heat-inactivated, severely hemolyzed, or lipemic are unacceptable. False positive results can occur. Repeated freeze/thaw cycles of specimens should be avoided.
New York Approved
Methodology
Immunoassay (CLIA)
Biomarkers
LOINC Codes
- 13951-9
Result Turnaround Time
0-1 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
ARUP standard transport tube
Collection Instructions
Separate serum from cells as soon as possible or within 2 hours of collection.
Storage Instructions
Refrigerated storage is required.
Causes for Rejection
Specimens collected in citrate-based anticoagulant. Specimens containing particulate material. Heat-inactivated, severely hemolyzed, or lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unacceptable |
| Refrigerated | 1 week |
| Frozen | Indefinitely |